Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study ; volume:26 ; number:1 ; day:19 ; month:9 ; year:2014 ; pages:361-372 ; date:1.2015
Osteoporosis international ; 26, Heft 1 (19.9.2014), 361-372, 1.2015
- Creator
-
Silverman, S. L.
Siris, E.
Kendler, D. L.
Belazi, D.
Brown, J. P.
Gold, D. T.
Lewiecki, E. M.
Papaioannou, A.
Simonelli, C.
Ferreira, I.
Balasubramanian, A.
Dakin, P.
Ho, P.
Siddhanti, S.
Stolshek, B.
Recknor, C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00198-014-2871-6
- URN
-
urn:nbn:de:101:1-2019063020081418642357
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Silverman, S. L.
- Siris, E.
- Kendler, D. L.
- Belazi, D.
- Brown, J. P.
- Gold, D. T.
- Lewiecki, E. M.
- Papaioannou, A.
- Simonelli, C.
- Ferreira, I.
- Balasubramanian, A.
- Dakin, P.
- Ho, P.
- Siddhanti, S.
- Stolshek, B.
- Recknor, C.
- SpringerLink (Online service)
Other Objects (12)
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Factors associated with high 24-month persistence with denosumab : results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
Postmenopausal osteoporosis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
Treatment of osteoporosis with denosumab in patients with decreased kidney function
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Factors associated with high 24-month persistence with denosumab : results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
Postmenopausal osteoporosis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
Treatment of osteoporosis with denosumab in patients with decreased kidney function
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Factors associated with high 24-month persistence with denosumab : results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium
Postmenopausal osteoporosis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
Treatment of osteoporosis with denosumab in patients with decreased kidney function
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab